Last reviewed · How we verify

NCT06150677

Effects of Static Apnea at High Lung Volume on Hypoalgesia, Cardiovascular Function and Respiratory Function

Status unknown Phase 3 Last updated 5 January 2024
What this trial tests

Phase 3 trial testing Voluntary apnoea in Pain in 60 participants. Status unknown.

Timeline
1 December 2023
Primary endpoint
1 May 2025
1 May 2025

Quick facts

Lead sponsorCentro Universitario La Salle
PhasePhase 3
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment60
Start date1 December 2023
Primary completion1 May 2025
Estimated completion1 May 2025
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Centro Universitario La Salle

Who can join

Adults 18 to 65, any sex, with Pain or Hypoxia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this randomized controlled study is to explore the hypoalgesic response of a 6 minutes of intermittent static apneas training session at high lung volume in healthy subjects; also, as secondary objectives, to analyze the cardiovascular and respiratory response produced during the intervention.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Voluntary apnoea

Trials testing the same drug.

Other recruiting trials for Pain

Currently open trials in the same condition.

Other Centro Universitario La Salle trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06150677.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing